AbClon Inc (174900) - Net Assets

Latest as of September 2025: ₩29.07 Billion KRW ≈ $19.70 Million USD

Based on the latest financial reports, AbClon Inc (174900) has net assets worth ₩29.07 Billion KRW (≈ $19.70 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩38.50 Billion ≈ $26.09 Million USD) and total liabilities (₩9.44 Billion ≈ $6.40 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check AbClon Inc (174900) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	₩29.07 Billion
% of Total Assets	75.49%
Annual Growth Rate	9.21%
5-Year Change	0.26%
10-Year Change	N/A
Growth Volatility	44.32

AbClon Inc - Net Assets Trend (2015–2024)

This chart illustrates how AbClon Inc's net assets have evolved over time, based on quarterly financial data. Also explore 174900 current and non-current assets for the complete picture of this company's asset base.

Annual Net Assets for AbClon Inc (2015–2024)

The table below shows the annual net assets of AbClon Inc from 2015 to 2024. For live valuation and market cap data, see how much is AbClon Inc worth.

Year	Net Assets	Change
2024-12-31	₩29.41 Billion ≈ $19.93 Million	+7.98%
2023-12-31	₩27.23 Billion ≈ $18.46 Million	-25.60%
2022-12-31	₩36.60 Billion ≈ $24.81 Million	+89.08%
2021-12-31	₩19.36 Billion ≈ $13.12 Million	-33.99%
2020-12-31	₩29.33 Billion ≈ $19.88 Million	-17.10%
2019-12-31	₩35.38 Billion ≈ $23.98 Million	+89.20%
2018-12-31	₩18.70 Billion ≈ $12.67 Million	+7.51%
2017-12-31	₩17.39 Billion ≈ $11.79 Million	+45.19%
2016-12-31	₩11.98 Billion ≈ $8.12 Million	-9.98%
2015-12-31	₩13.31 Billion ≈ $9.02 Million	--

Equity Component Analysis

This analysis shows how different components contribute to AbClon Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 5660985445000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Common Stock	₩8.71 Billion	29.63%
Other Components	₩93.58 Billion	318.22%
Total Equity	₩29.41 Billion	100.00%

AbClon Inc Competitors by Market Cap

The table below lists competitors of AbClon Inc ranked by their market capitalization.

Company	Market Cap
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited STU:2TZ	$635.99 Million
Matrix Concepts Holdings Bhd KLSE:5236	$636.20 Million
Bajaj Consumer Care Limited NSE:BAJAJCON	$636.30 Million
China Railway Harbin Group of Technology Corp. A SHG:688459	$636.37 Million
Shenzhen Water Planning & Design Institute Co. Ltd. SHE:301038	$635.90 Million
E&R Engineering TWO:8027	$635.83 Million
BlackRock Utility & Infrastructure Trust NYSE:BUI	$635.64 Million
Zhejiang Gongdong Medical Technology Co Ltd SHG:605369	$635.62 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in AbClon Inc's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 27,232,482,590 to 29,405,991,610, a change of 2,173,509,020 (8.0%).
Net loss of 16,301,551,980 reduced equity.
Share repurchases of 17,000,000 reduced equity.
New share issuances of 8,916,920,170 increased equity.
Other factors increased equity by 9,575,140,830.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	₩-16.30 Billion	-55.44%
Share Repurchases	₩17.00 Million	-0.06%
Share Issuances	₩8.92 Billion	+30.32%
Other Changes	₩9.58 Billion	+32.56%
Total Change	₩-	7.98%

Book Value vs Market Value Analysis

This analysis compares AbClon Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 29.12x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 50.05x to 29.12x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2016-12-31	₩982.08	₩49150.00	x
2017-12-31	₩1278.84	₩49150.00	x
2018-12-31	₩1305.79	₩49150.00	x
2019-12-31	₩2465.05	₩49150.00	x
2020-12-31	₩1919.69	₩49150.00	x
2021-12-31	₩1267.10	₩49150.00	x
2022-12-31	₩2389.56	₩49150.00	x
2023-12-31	₩1753.50	₩49150.00	x
2024-12-31	₩1687.56	₩49150.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently AbClon Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -55.44%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -696.70%
• Asset Turnover: 0.05x
• Equity Multiplier: 1.64x
Recent ROE (-55.44%) is below the historical average (-29.60%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2015	-73.96%	-505.24%	0.12x	1.21x	₩-11.17 Billion
2016	-13.33%	-51.17%	0.19x	1.34x	₩-2.79 Billion
2017	-8.52%	-41.97%	0.17x	1.20x	₩-3.22 Billion
2018	-4.51%	-21.49%	0.14x	1.54x	₩-2.71 Billion
2019	7.25%	17.85%	0.31x	1.33x	₩-971.27 Million
2020	-21.97%	-232.57%	0.07x	1.37x	₩-9.38 Billion
2021	-52.88%	-339.22%	0.10x	1.54x	₩-12.17 Billion
2022	-25.28%	-271.66%	0.06x	1.48x	₩-12.91 Billion
2023	-47.39%	-448.53%	0.06x	1.67x	₩-15.63 Billion
2024	-55.44%	-696.70%	0.05x	1.64x	₩-19.24 Billion

Industry Comparison

This section compares AbClon Inc's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

Industry: Biotechnology
Average net assets among peers: $368,573,438,392
Average return on equity (ROE) among peers: 0.96%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
AbClon Inc (174900)	₩29.07 Billion	-73.96%	0.32x	$635.95 Million
ORIENTBIO Inc. (002630)	$57.60 Billion	0.00%	0.70x	$43.15 Million
Green Cross (005250)	$1.51 Trillion	0.20%	0.84x	$425.10 Million
Green Cross Holdings Preference Shares (005257)	$1.85 Trillion	1.30%	0.98x	$3.74 Million
Pharmicell (005690)	$51.52 Billion	8.44%	0.23x	$736.42 Million
GeneOne Life Science Inc (011000)	$39.74 Billion	0.00%	0.49x	$49.94 Million
HLB Co. Ltd (028300)	$19.44 Billion	0.00%	0.66x	$5.41 Billion
Daesung Microbiological Labs. Co. Ltd (036480)	$37.00 Billion	2.34%	0.69x	$19.29 Million
Seoulin Bioscience Co.Ltd (038070)	$51.49 Billion	4.00%	0.38x	$37.92 Million
Hyundai Bioscience Co. Ltd (048410)	$58.24 Billion	3.27%	0.77x	$872.13 Million
iNtRON Biotechnology Inc (048530)	$11.93 Billion	-9.93%	0.65x	$77.34 Million

About AbClon Inc

KQ:174900 Korea Biotechnology

Market Cap

$635.95 Million

₩938.42 Billion KRW

Market Cap Rank

#11309 Global

#346 in Korea

Share Price

₩49150.00

Change (1 day)

-2.48%

52-Week Range

₩9630.00 - ₩89100.00

All Time High

₩90600.00